Search
for
Sort by
Research 271–300 of 444
- Primary cicatricial alopecia
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Biomaterials for in situ tissue regeneration: development and perspectives
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- Cutaneous Manifestations of Eating Disorders
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- ANDROGENETIC ALOPECIA
- Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
- Clinical applications of antiandrogens
- Lupus panniculitis clinically simulating alopecia areata
- Androgen antagonists in androgen target tissues
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Novel iron oxide nanocarriers loading finasteride or dutasteride: Enhanced skin penetration for topical treatment of alopecia
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- LETTERS TO THE EDITOR
- An overview of management of drug-induced hair and nail disorders
- Modulating testosterone pathway: a new strategy to tackle male skin aging?
- Hereditary Hypotrichosis and Localized Morphea: A New Clinical Entity
- Herbal Hair Gel Formulation having 5α-Reductase Inhibitory Activity and its Standardization by HPTLC
- Severe Hyperandrogenemia and Insulin Resistance in a 12-Year-Old Girl
- Skin aging: mechanisms, evaluation, and rejuvenation
- Autoimmunity and clinical pathology amelioration in SLE by Dexamethasone primed Mesenchymal Stem Cell derived conditioned media